5 unknown. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Unknown 5 |
| Phase 2 | 2 | Unknown 2 |
Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer Fluzoparib, Apatinib Mesylate - Epithelial Ovarian Cancer, Efficacy | Phase 3 | Unknown | Anhui Provincial Hospital | 51 | 2024-10-01 | 2024-08-06 |
| A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2; - Immunogenicity, Safety | Phase 2 / Phase 3 | Unknown | Stemirna Therapeutics | 800 | 2023-06-20 | 2023-06-20 |
| mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2., Pfizer(BNT162b2);SARS-Cov-2. - Immunogenicity, Safety | Phase 3 | Unknown | Stemirna Therapeutics | 600 | 2022-10-19 | 2023-01-17 |
| New Generation mRNA Booster Vaccine Against Emerging VOCs SW-BIC-213, SARS-Cov-2 Vaccina(Vero Cell ) Inactivated - Immunogenicity, Efficacy | Phase 3 | Unknown | Stemirna Therapeutics | 2000 | 2022-10-01 | 2023-04-12 |
| Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients Advixa (Adalimumab) - Pharmacokinetics, Safety | Phase 2 / Phase 3 | Unknown | Institute for Developing Science and Health Initiatives, Bangladesh | 200 | 2021-06-02 | 2022-07-07 |
Arthritis, Rheumatoid (1) · Carcinoma, Ovarian Epithelial (1)
Adnexal Diseases (1) · Arthritis (1) · Autoimmune Diseases (1) · Carcinoma (1) · Connective Tissue Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Immune System Diseases (1) · Joint Diseases (1)
Adalimumab (1) · apatinib (1) · fluzoparib (1)
Stemirna Therapeutics (3) · Anhui Provincial Hospital (1) · Institute for Developing Science and Health Initiatives, Bangladesh (1)
Laos (2) · Bangladesh (1)
Mayfong Mayxay, doctor (3) · Ying Zhou, MD (1) · Zannat Kawser, M.Phil. (1)